Évolution de la cellule normale à la cellule cancéreuse prostatique hormonodépendante–hormono-indépendante

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Medecine Nucleaire-imagerie Fonctionnelle Et Metabolique

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1016/J.MEDNUC.2007.11.002
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Adrenomedullin, an autocrine/paracrine factor induced by androgen withdrawal, stimulates ‘neuroendocrine phenotype’ in LNCaP prostate tumor cells

  2008cited by this paper
• Effects of adrenomedullin on endothelial cells in the multistep process of angiogenesis: Involvement of CRLR/RAMP2 and CRLR/RAMP3 receptors

  2004cited by this paper
• Characterization of adrenomedullin in non-human primates.

  2004cited by this paper
• Endocrine treatment of prostate cancer.

  2004cited by this paper
• Molecular analysis integrating different pathways associated with androgen-independent progression in LuCaP 23.1 xenograft

  2004cited by this paper
• Neuroendocrine differentiation in hormone refractory prostate cancer following androgen deprivation therapy.

  2004cited by this paper
• Membrane androgen binding sites are preferentially expressed in human prostate carcinoma cells

  2003cited by this paper
• Androgen-stimulated DNA synthesis and cytoskeletal changes in fibroblasts by a nontranscriptional receptor action

  2003cited by this paper
• Role of the stromal microenvironment in carcinogenesis of the prostate

  2003cited by this paper
• Prostate carcinoma bone‐stroma interaction and its biologic and therapeutic implications

  2003cited by this paper
• Non-genomic actions of sex steroid hormones.

  2003cited by this paper
• The embedded tumour: host physiology is important for the evaluation of tumour growth

  2003cited by this paper
• Inactivation of androgen receptor coregulator ARA55 inhibits androgen receptor activity and agonist effect of antiandrogens in prostate cancer cells

  2003cited by this paper
• β-Catenin Binds to the Activation Function 2 Region of the Androgen Receptor and Modulates the Effects of the N-Terminal Domain and TIF2 on Ligand-Dependent Transcription

  2003cited by this paper
• Combined loss of PTEN and p27 expression is associated with tumor cell proliferation by Ki-67 and increased risk of recurrent disease in localized prostate cancer.

  2003cited by this paper
• Constitutive activation of the Ras/mitogen-activated protein kinase signaling pathway promotes androgen hypersensitivity in LNCaP prostate cancer cells.

  2003cited by this paper
• Selective modulation of genomic and nongenomic androgen responses by androgen receptor ligands.

  2003cited by this paper
• Cloning, expression, and characterization of a membrane progestin receptor and evidence it is an intermediary in meiotic maturation of fish oocytes

  2003cited by this paper
• Resistance to cytotoxic chemotherapy-induced apoptosis in human prostate cancer cells is associated with intracellular clusterin expression.

  2003cited by this paper
• Filamin-A fragment localizes to the nucleus to regulate androgen receptor and coactivator functions

  2003cited by this paper
• Monitoring bone density in hypogonadal men by quantitative phalangeal ultrasound.

  2002cited by this paper
• Antiandrogens: selective androgen receptor modulators.

  2002cited by this paper
• AR and ER interaction with a p21-activated kinase (PAK6).

  2002cited by this paper
• Androgen-selective gene regulation in the prostate.

  2002cited by this paper
• Activation of the Androgen Receptor N-terminal Domain by Interleukin-6 via MAPK and STAT3 Signal Transduction Pathways*

  2002cited by this paper
• Prostate tumor-stroma interaction: molecular mechanisms and opportunities for therapeutic targeting.

  2002cited by this paper
• Nongenomic Testosterone Calcium Signaling

  2002cited by this paper
• The presence of both the amino- and carboxyl-terminal domains in the AR is essential for the completion of a transcriptionally active form with coactivators and intranuclear compartmentalization common to the steroid hormone receptors: a three-dimensional imaging study.

  2002cited by this paper
• Vascular reactivity in hypogonadal men is reduced by androgen substitution.

  2002cited by this paper
• Rapid Actions of Steroid Receptors in Cellular Signaling Pathways

  2002cited by this paper
• Association of preoperative plasma levels of insulin-like growth factor I and insulin-like growth factor binding proteins-2 and -3 with prostate cancer invasion, progression, and metastasis.

  2002cited by this paper
• Androgen ablation promotes neuroendocrine cell differentiation in dog and human prostate

  2002cited by this paper
• Clusterin expression is significantly enhanced in prostate cancer cells following androgen withdrawal therapy

  2002cited by this paper
• Adrenomedullin and proadrenomedullin N‐terminal 20 peptide in the normal prostate and in prostate carcinoma

  2002cited by this paper
• Mechanisms involved in the progression of androgen-independent prostate cancers: it is not only the cancer cell's fault.

  2002cited by this paper
• Amplification of the androgen receptor gene in bone metastases from hormone‐refractory prostate cancer

  2002cited by this paper
• Reversal of Bone Loss in Mice by Nongenotropic Signaling of Sex Steroids

  2002cited by this paper
• The roles of androgen receptors and androgen-binding proteins in nongenomic androgen actions.

  2002cited by this paper
• Expression of RAC 3, a steroid hormone receptor co-activator in prostate cancer

  2001cited by this paper
• Expression of adrenomedullin and peptide amidation activity in human prostate cancer and in human prostate cancer cell lines.

  2001cited by this paper
• Caveolin-1 Interacts with Androgen Receptor

  2001cited by this paper
• Mutations of the asparagine117 residue of a receptor activity-modifying protein 1-dependent human calcitonin gene-related peptide receptor result in selective loss of function.

  2001cited by this paper
• ADRENAL STEROIDS IN HUMAN PROSTATIC CANCER CELL LINES

  2001cited by this paper
• The Seven Amino Acids of Human RAMP2 (86) and RAMP3 (59) Are Critical for Agonist Binding to Human Adrenomedullin Receptors*

  2001cited by this paper
• Testosterone dose-response relationships in healthy young men.

  2001cited by this paper
• Signalling pathways involved in antiproliferative effects of IGFBP-3: a review

  2001cited by this paper
• Androgen receptor: pathophysiology

  2001cited by this paper
• Effects of hyperprolactinemia on rat prostate growth: evidence of androgeno-dependence.

  2001cited by this paper
• Insulin-like growth factor-binding protein 2 in tumorigenesis: protector or promoter?

  2001cited by this paper
• Up-regulation of neuroendocrine differentiation in prostate cancer after androgen deprivation therapy, degree and androgen independence.

  2001cited by this paper
• Protein-Protein Interaction and Not Glycosylation Determines the Binding Selectivity of Heterodimers between the Calcitonin Receptor-like Receptor and the Receptor Activity-modifying Proteins*

  2001cited by this paper
• Advances in Brief Amplification and Overexpression of Androgen Receptor Gene in Hormone-Refractory Prostate Cancer 1

  2001cited by this paper
• The development of androgen-independent prostate cancer

  2001cited by this paper
• TGF-β signaling in tumor suppression and cancer progression

  2001cited by this paper
• How many nuclear hormone receptors are there in the human genome?

  2001cited by this paper
• Inhibition of Androgen Receptor-Mediated Transcription by Amino-Terminal Enhancer of split

  2001cited by this paper
• Androgen receptors and their biology.

  2001cited by this paper
• PDEF, a Novel Prostate Epithelium-specific Ets Transcription Factor, Interacts with the Androgen Receptor and Activates Prostate-specific Antigen Gene Expression*

  2000cited by this paper
• Adrenomedullin, a multifunctional regulatory peptide.

  2000cited by this paper
• Angiogenesis in cancer and other diseases

  2000cited by this paper
• Polymorphic CAG and GGN repeat lengths in the androgen receptor gene and prostate cancer risk: a population-based case-control study in China.

  2000cited by this paper
• Beta-catenin affects androgen receptor transcriptional activity and ligand specificity.

  2000cited by this paper
• [Genetics and urology].

  2000cited by this paper
• Correlation of preoperative plasma IGF-I levels with pathologic parameters and progression in patients undergoing radical prostatectomy.

  2000cited by this paper
• Akt Regulates Cell Survival and Apoptosis at a Postmitochondrial Level

  2000cited by this paper
• Role of the insulin-like growth factor family in cancer development and progression.

  2000cited by this paper
• Inhibition of p160-mediated coactivation with increasing androgen receptor polyglutamine length.

  2000cited by this paper
• Effect of the androgen receptor CAG repeat polymorphism on transcriptional activity: specificity in prostate and non-prostate cell lines.

  2000cited by this paper
• Genetic analysis of androgen receptors in development and disease.

  2000cited by this paper
• Role of insulin‐like growth factors and their binding proteins in growth control and carcinogenesis

  2000cited by this paper
• Glucocorticoids can promote androgen-independent growth of prostate cancer cells through a mutated androgen receptor

  2000cited by this paper
• Detection and analysis of β‐catenin mutations in prostate cancer

  2000cited by this paper
• Erratum: Glucocorticoids can promote androgen-independent growth of prostate cancer cells through a mutated androgen receptor (Nature Medicine (2000) 6 (703-706))

  2000cited by this paper
• Regulation of androgen action.

  1999cited by this paper
• Regulation of Apoptosis in the Prostate Gland by Androgenic Steroids.

  1999cited by this paper
• Serum insulin‐like growth factor‐1 is not a useful marker of prostate cancer

  1999cited by this paper
• (CAG)nCAA and GGN repeats in the human androgen receptor gene are not associated with prostate cancer in a French–German population

  1999cited by this paper
• The Linkage of Kennedy’s Neuron Disease to ARA24, the First Identified Androgen Receptor Polyglutamine Region-associated Coactivator*

  1999cited by this paper
• A mechanism for hormone-independent prostate cancer through modulation of androgen receptor signaling by the HER-2/neu tyrosine kinase

  1999cited by this paper
• The RAMP2/CRLR complex is a functional adrenomedullin receptor in human endothelial and vascular smooth muscle cells

  1999cited by this paper
• Ubc9 Interacts with the Androgen Receptor and Activates Receptor-dependent Transcription*

  1999cited by this paper
• Activation Function 2 in the Human Androgen Receptor Ligand Binding Domain Mediates Interdomain Communication with the NH2-terminal Domain*

  1999cited by this paper
• The biology of hormone refractory prostate cancer. Why does it develop?

  1999cited by this paper
• The AF1 and AF2 Domains of the Androgen Receptor Interact with Distinct Regions of SRC1

  1999cited by this paper
• PCR display identifies tamoxifen induction of the novel angiogenic factor adrenomedullin by a non estrogenic mechanism in the human endometrium

  1998cited by this paper
• Plasma Insulin-Like Growth Factor-I and Prostate Cancer Risk: A Prospective Study

  1998cited by this paper
• Promotion of agonist activity of antiandrogens by the androgen receptor coactivator, ARA70, in human prostate cancer DU145 cells.

  1998cited by this paper
• Androgen Metabolism and Prostate Cancer: Establishing a Model of Genetic Susceptibility

  1998cited by this paper
• The pathogenesis of benign prostatic hyperplasia: a proposed hypothesis and critical evaluation.

  1998cited by this paper
• Sex hormone‐induced prostatic carcinogenesis in the Noble rat: The role of insulin‐like growth factor‐1 (IGF‐1) and vascular endothelial growth factor (VEGF) in the development of prostate cancer

  1998cited by this paper
• RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor

  1998cited by this paper
• Allosteric effects of DNA on transcriptional regulators

  1998cited by this paper
• Functional interactions of the AF-2 activation domain core region of the human androgen receptor with the amino-terminal domain and with the transcriptional coactivator TIF2 (transcriptional intermediary factor2).

  1998cited by this paper
• Trinucleotide repeats in the human androgen receptor: a molecular basis for disease.

  1998cited by this paper
• A Novel Coculture Model for Benign Prostatic Hyperplasia Expressing Both Isoforms of 5α-Reductase1

  1998cited by this paper
• Intermolecular NH2-/Carboxyl-terminal Interactions in Androgen Receptor Dimerization Revealed by Mutations That Cause Androgen Insensitivity*

  1998cited by this paper
• Growth factor involvement in progression of prostate cancer.

  1998cited by this paper
• Insulin-like Growth Factor (IGF)-binding Protein-3 Induces Apoptosis and Mediates the Effects of Transforming Growth Factor-β1 on Programmed Cell Death through a p53- and IGF-independent Mechanism*

  1997cited by this paper
• Androgen receptor gene amplification: a possible molecular mechanism for androgen deprivation therapy failure in prostate cancer.

  1997cited by this paper
• Transcriptional up-regulation of the human androgen receptor by androgen in bone cells.

  1997cited by this paper

• Effets antiandrogéniques de pesticides dans les cellules cancéreuses corticosurrénales humaines (h295r) et de la prostate humaines (lncap)

  2014influential citation